Olema Pharmaceuticals, Inc. (OLMA) NASDAQ
10.69
-2.02(-15.89%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Olema Pharmaceuticals, Inc.
Address
512 2nd Street
San Francisco, CA 94107
United States of America (the)
Phone
650 243 5555
Website
Sector
Healthcare
Industry
Biotechnology
Employees
96
First IPO Date
November 19, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Sean Bohen | President, CEO, Interim Principal Financial Officer & Director | 1.18M | 1967 |
| David C. Myles | Chief Scientific Officer | 200,000 | 1963 |
| Shawnte Mitchell | Chief Legal Officer & Corporate Secretary | 664,750 | 1978 |
| Naseem Zojwalla | Chief Medical Officer | 777,970 | 1973 |
| Shane William Charles Kovacs | Consultant | 902,735 | 1974 |
| Angelos Dovletoglou | Senior Vice President of CMC & Supply Chain | 0 | N/A |
| Julie Dexter | Senior Vice President & Head of People | 0 | N/A |
| Meghna Chowdary | Senior Vice President of Commercial Strategy & Operations | 0 | N/A |
| Sasha Austin | Vice President of Finance & Controller | 0 | N/A |
| Courtney O'Konek | Vice President of Corporate Communications | 0 | N/A |
| Mark Shilkrut | Senior Vice President of Clinical Development | 0 | N/A |
| Kamesh Kuchimanchi | Senior Vice President of Regulatory Affairs & Quality Assurance | 0 | N/A |
| Richard Hernandez | Senior Vice President of Clinical Development Operations | 0 | N/A |
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
